deprivation

(redirected from androgen deprivation)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to androgen deprivation: Androgen Deprivation Therapy

deprivation

the lack of economic and emotional supports generally accepted as basic essentials of human experience. These include income and housing, and parental care (or an adequate substitute) for children. This recognizes that care, shelter and security are human needs (see also HUMANISTIC PSYCHOLOGY, MASLOW) the possession of which leads to a fuller, more comfortable life experience and allows a more complete development of the individual's potential. See also CYCLE OF DEPRIVATION, POVERTY, RELATIVE DEPRIVATION.

Deprivation

 

sensory insufficiency or inadequate load on the system of analysors observed in man when isolated or when the functioning of the main sense organs is impaired. Astronauts, speleologists, and others experience the phenomenon of deprivation. The depth of the psychological, autonomic, and somatic changes in deprivation is determined chiefly by its intensity and duration, as well as by individual personality traits. If work capacity and mental health are to be retained under conditions of deprivation, it is very important that the work be organized efficiently and that specific steps be taken to increase the reliability of the auditory, visual, interoceptive, and other information.

REFERENCE

Banshchikov, V. M., and G. V. Stoliarov. “Sensornaia izoliatsiia.” Zhurnal nevropatologii ipsikhiatrii im. S. S. Korsakova, 1966, no. 9, pp. 1428–40.
References in periodicals archive ?
Concluded that androgen deprivation therapy may be associated with a greater incidence of diabetes and cardiovascular disease owing to adverse effects of ADT i.
Hot flushes are the most common side-effects of androgen deprivation therapy (ADT).
Comment: Androgen deprivation therapy has previously been shown to reduce mortality in patients with high-risk (poorly differentiated or advanced) prostate cancer.
Typical side effects of androgen deprivation therapy include hot flashes, loss of libido, and impotence.
There is a clear, unmet medical need for new treatment options for prostate cancer patients, especially those with castration-resistant prostate cancer who often become resistant to androgen deprivation therapy," commented Dr.
The submission is based on data from the SPARTAN Phase 3 clinical trial which assessed the safety and efficacy of apalutamide versus placebo in men with nmCRPC who have a rapidly rising prostate specific antigen level, despite receiving continuous androgen deprivation therapy.
This NDA submission for apalutamide was based on the company's Phase 3 data from the pivotal ARN-509-003 (SPARTAN) clinical trial, which assessed the safety and efficacy of apalutamide versus placebo in men with non-metastatic CRPC who have a rapidly rising prostate specific antigen (PSA) despite receiving continuous androgen deprivation therapy (ADT).
This submission is based on Phase 3 data from the pivotal ARN-509-003 (SPARTAN) clinical trial, which assessed the safety and efficacy of apalutamide versus placebo, in men with non-metastatic CRPC who have a rapidly rising prostate specific antigen (PSA) despite receiving continuous androgen deprivation therapy (ADT).
Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy.
Androgen deprivation therapy stops the male hormone testosterone from reaching prostate cancer cells and fuelling their growth.
Enzalutamide will help patients with metastatic castration-resistant prostate cancer (mCRPC) who still show signs of the condition after going through androgen deprivation therapy.

Full browser ?